Literature DB >> 1729748

Anastomotic stricture with the EEA stapler after colorectal operation in the dog.

T Yamane1, T Takahashi, J Okuzumi, Y Fujita.   

Abstract

Anastomosis of the gastrointestinal tract has been made more secure by the use of the EEA (U. S. Surgical Corp.) stapler. The development of anastomotic strictures after stapling anastomosis is one of the major postoperative complications of this method. This study was done to compare the incidence of anastomotic stricture between stapling anastomosis and layer-to-layer handsewn anastomosis. Twelve dogs were divided into two groups. In each group, two colonic anastomoses were performed. Intestinal contents were not allowed to pass through one of the anastomotic sites created in an isolated segment of the colon, but were allowed to pass through the other site in the remaining colon. By the 28th postoperative day, anastomoses made with the EEA stapler, which had been excluded from contact with feces, had developed significantly more strictures when compared with the other anastomoses (p less than 0.05). The anastomotic strictures were membranous in nature when examined macroscopically and histologically.

Entities:  

Mesh:

Year:  1992        PMID: 1729748

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  3 in total

1.  A new device for the treatment of coloproctostomic stricture after double stapling anastomoses.

Authors:  S Shimada; M Matsuda; K Uno; H Matsuzaki; S Murakami; M Ogawa
Journal:  Ann Surg       Date:  1996-11       Impact factor: 12.969

2.  Long-term prospective evaluation of intestinal anastomosis using stainless steel staples in 14 dogs.

Authors:  Manuel Benlloch-Gonzalez; Eymeric Gomes; Bernard Bouvy; Cyrill Poncet
Journal:  Can Vet J       Date:  2015-07       Impact factor: 1.008

3.  Efficacy of dilatations for anastomotic colorectal stenoses: prognostic factors.

Authors:  S Pucciarelli; P Toppan; P L Pilati; A Piccoli; F Chemello; M Lise
Journal:  Int J Colorectal Dis       Date:  1994-08       Impact factor: 2.571

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.